aluates Reports

$ 0.0

Automative

Global Apomorphine Delivery Device Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-15C8547

Global Apomorphine Delivery Device Market Insights and Forecast to 2028

BUY CHAPTERS

Global Apomorphine Delivery Device Market Insights, Forecast to 2030

Code: QYRE-Auto-15C8547

Report

December 2024

Pages:71

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Supernus Pharmaceuticals

Britannia Pharmaceuticals STADA

EVER Pharma

Evolan Pharma AB (PharmSwed)

Apomorphine Delivery Device Market

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.

The global Apomorphine Delivery Device market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Apomorphine Delivery Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Apomorphine Delivery Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Apomorphine Delivery Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Apomorphine Delivery Device include Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma and Evolan Pharma AB (PharmSwed), etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Covers:

This report presents an overview of global market for Apomorphine Delivery Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Apomorphine Delivery Device, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Apomorphine Delivery Device, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Apomorphine Delivery Device sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Apomorphine Delivery Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Apomorphine Delivery Device sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Apomorphine Delivery Device Market Report

Report Metric	Details
Report Name	Apomorphine Delivery Device Market
Segment by Type	Pen Injectors Infusion Pumps
Segment by Application	Parkinson Disease Erectile Dysfunction
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Ever Pharma, Evolan Pharma AB (PharmSwed)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Apomorphine Delivery Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Apomorphine Delivery Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Apomorphine Delivery Device sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Apomorphine Delivery Device Market report?

Ans: The main players in the Apomorphine Delivery Device Market are Ever Pharma, Evolan Pharma AB (PharmSwed)

What are the Application segmentation covered in the Apomorphine Delivery Device Market report?

Ans: The Applications covered in the Apomorphine Delivery Device Market report are Parkinson Disease, Erectile Dysfunction

What are the Type segmentation covered in the Apomorphine Delivery Device Market report?

Ans: The Types covered in the Apomorphine Delivery Device Market report are Pen Injectors, Infusion Pumps

Recommended Reports

Drug Delivery Devices

Neurological Therapy Devices

Pain & Disease Management

1 Study Coverage

1.1 Apomorphine Delivery Device Product Introduction

1.2 Market by Type

1.2.1 Global Apomorphine Delivery Device Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Pen Injectors

1.2.3 Infusion Pumps

1.3 Market by Application

1.3.1 Global Apomorphine Delivery Device Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Parkinson Disease

1.3.3 Erectile Dysfunction

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Apomorphine Delivery Device Sales Estimates and Forecasts 2019-2030

2.2 Global Apomorphine Delivery Device Revenue by Region

2.2.1 Global Apomorphine Delivery Device Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Apomorphine Delivery Device Revenue by Region (2019-2024)

2.2.3 Global Apomorphine Delivery Device Revenue by Region (2025-2030)

2.2.4 Global Apomorphine Delivery Device Revenue Market Share by Region (2019-2030)

2.3 Global Apomorphine Delivery Device Sales Estimates and Forecasts 2019-2030

2.4 Global Apomorphine Delivery Device Sales by Region

2.4.1 Global Apomorphine Delivery Device Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Apomorphine Delivery Device Sales by Region (2019-2024)

2.4.3 Global Apomorphine Delivery Device Sales by Region (2025-2030)

2.4.4 Global Apomorphine Delivery Device Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Apomorphine Delivery Device Sales by Manufacturers

3.1.1 Global Apomorphine Delivery Device Sales by Manufacturers (2019-2024)

3.1.2 Global Apomorphine Delivery Device Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Apomorphine Delivery Device in 2023

3.2 Global Apomorphine Delivery Device Revenue by Manufacturers

3.2.1 Global Apomorphine Delivery Device Revenue by Manufacturers (2019-2024)

3.2.2 Global Apomorphine Delivery Device Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Apomorphine Delivery Device Revenue in 2023

3.3 Global Key Players of Apomorphine Delivery Device, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Apomorphine Delivery Device Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Apomorphine Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Apomorphine Delivery Device, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Apomorphine Delivery Device, Product Offered and Application

3.8 Global Key Manufacturers of Apomorphine Delivery Device, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Apomorphine Delivery Device Sales by Type

4.1.1 Global Apomorphine Delivery Device Historical Sales by Type (2019-2024)

4.1.2 Global Apomorphine Delivery Device Forecasted Sales by Type (2025-2030)

4.1.3 Global Apomorphine Delivery Device Sales Market Share by Type (2019-2030)

4.2 Global Apomorphine Delivery Device Revenue by Type

4.2.1 Global Apomorphine Delivery Device Historical Revenue by Type (2019-2024)

4.2.2 Global Apomorphine Delivery Device Forecasted Revenue by Type (2025-2030)

4.2.3 Global Apomorphine Delivery Device Revenue Market Share by Type (2019-2030)

4.3 Global Apomorphine Delivery Device Price by Type

4.3.1 Global Apomorphine Delivery Device Price by Type (2019-2024)

4.3.2 Global Apomorphine Delivery Device Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Apomorphine Delivery Device Sales by Application

5.1.1 Global Apomorphine Delivery Device Historical Sales by Application (2019-2024)

5.1.2 Global Apomorphine Delivery Device Forecasted Sales by Application (2025-2030)

5.1.3 Global Apomorphine Delivery Device Sales Market Share by Application (2019-2030)

5.2 Global Apomorphine Delivery Device Revenue by Application

5.2.1 Global Apomorphine Delivery Device Historical Revenue by Application (2019-2024)

5.2.2 Global Apomorphine Delivery Device Forecasted Revenue by Application (2025-2030)

5.2.3 Global Apomorphine Delivery Device Revenue Market Share by Application (2019-2030)

5.3 Global Apomorphine Delivery Device Price by Application

5.3.1 Global Apomorphine Delivery Device Price by Application (2019-2024)

5.3.2 Global Apomorphine Delivery Device Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Apomorphine Delivery Device Market Size by Type

6.1.1 US & Canada Apomorphine Delivery Device Sales by Type (2019-2030)

6.1.2 US & Canada Apomorphine Delivery Device Revenue by Type (2019-2030)

6.2 US & Canada Apomorphine Delivery Device Market Size by Application

6.2.1 US & Canada Apomorphine Delivery Device Sales by Application (2019-2030)

6.2.2 US & Canada Apomorphine Delivery Device Revenue by Application (2019-2030)

6.3 US & Canada Apomorphine Delivery Device Market Size by Country

6.3.1 US & Canada Apomorphine Delivery Device Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Apomorphine Delivery Device Sales by Country (2019-2030)

6.3.3 US & Canada Apomorphine Delivery Device Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Apomorphine Delivery Device Market Size by Type

7.1.1 Europe Apomorphine Delivery Device Sales by Type (2019-2030)

7.1.2 Europe Apomorphine Delivery Device Revenue by Type (2019-2030)

7.2 Europe Apomorphine Delivery Device Market Size by Application

7.2.1 Europe Apomorphine Delivery Device Sales by Application (2019-2030)

7.2.2 Europe Apomorphine Delivery Device Revenue by Application (2019-2030)

7.3 Europe Apomorphine Delivery Device Market Size by Country

7.3.1 Europe Apomorphine Delivery Device Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Apomorphine Delivery Device Sales by Country (2019-2030)

7.3.3 Europe Apomorphine Delivery Device Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Apomorphine Delivery Device Market Size

8.1.1 China Apomorphine Delivery Device Sales (2019-2030)

8.1.2 China Apomorphine Delivery Device Revenue (2019-2030)

8.2 China Apomorphine Delivery Device Market Size by Application

8.2.1 China Apomorphine Delivery Device Sales by Application (2019-2030)

8.2.2 China Apomorphine Delivery Device Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Apomorphine Delivery Device Market Size by Type

9.1.1 Asia Apomorphine Delivery Device Sales by Type (2019-2030)

9.1.2 Asia Apomorphine Delivery Device Revenue by Type (2019-2030)

9.2 Asia Apomorphine Delivery Device Market Size by Application

9.2.1 Asia Apomorphine Delivery Device Sales by Application (2019-2030)

9.2.2 Asia Apomorphine Delivery Device Revenue by Application (2019-2030)

9.3 Asia Apomorphine Delivery Device Sales by Region

9.3.1 Asia Apomorphine Delivery Device Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Apomorphine Delivery Device Revenue by Region (2019-2030)

9.3.3 Asia Apomorphine Delivery Device Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Apomorphine Delivery Device Market Size by Type

10.1.1 Middle East, Africa and Latin America Apomorphine Delivery Device Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Apomorphine Delivery Device Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Apomorphine Delivery Device Market Size by Application

10.2.1 Middle East, Africa and Latin America Apomorphine Delivery Device Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Apomorphine Delivery Device Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Apomorphine Delivery Device Sales by Country

10.3.1 Middle East, Africa and Latin America Apomorphine Delivery Device Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Apomorphine Delivery Device Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Apomorphine Delivery Device Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Supernus Pharmaceuticals

11.1.1 Supernus Pharmaceuticals Company Information

11.1.2 Supernus Pharmaceuticals Overview

11.1.3 Supernus Pharmaceuticals Apomorphine Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Supernus Pharmaceuticals Apomorphine Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Supernus Pharmaceuticals Recent Developments

11.2 Britannia Pharmaceuticals STADA

11.2.1 Britannia Pharmaceuticals STADA Company Information

11.2.2 Britannia Pharmaceuticals STADA Overview

11.2.3 Britannia Pharmaceuticals STADA Apomorphine Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Britannia Pharmaceuticals STADA Apomorphine Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Britannia Pharmaceuticals STADA Recent Developments

11.3 Ever Pharma

11.3.1 Ever Pharma Company Information

11.3.2 Ever Pharma Overview

11.3.3 Ever Pharma Apomorphine Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Ever Pharma Apomorphine Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Ever Pharma Recent Developments

11.4 Evolan Pharma AB (PharmSwed)

11.4.1 Evolan Pharma AB (PharmSwed) Company Information

11.4.2 Evolan Pharma AB (PharmSwed) Overview

11.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Evolan Pharma AB (PharmSwed) Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Apomorphine Delivery Device Industry Chain Analysis

12.2 Apomorphine Delivery Device Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Apomorphine Delivery Device Production Mode & Process

12.4 Apomorphine Delivery Device Sales and Marketing

12.4.1 Apomorphine Delivery Device Sales Channels

12.4.2 Apomorphine Delivery Device Distributors

12.5 Apomorphine Delivery Device Customers

13 Market Dynamics

13.1 Apomorphine Delivery Device Industry Trends

13.2 Apomorphine Delivery Device Market Drivers

13.3 Apomorphine Delivery Device Market Challenges

13.4 Apomorphine Delivery Device Market Restraints

14 Key Findings in The Global Apomorphine Delivery Device Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Supernus Pharmaceuticals

Britannia Pharmaceuticals STADA

EVER Pharma

Evolan Pharma AB (PharmSwed)

List of Tables

Table 1. Global Apomorphine Delivery Device Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Pen Injectors

Table 3. Major Manufacturers of Infusion Pumps

Table 4. Global Apomorphine Delivery Device Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Apomorphine Delivery Device Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Apomorphine Delivery Device Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Apomorphine Delivery Device Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Apomorphine Delivery Device Revenue Market Share by Region (2019-2024)

Table 9. Global Apomorphine Delivery Device Revenue Market Share by Region (2025-2030)

Table 10. Global Apomorphine Delivery Device Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Apomorphine Delivery Device Sales by Region (2019-2024) & (K Units)

Table 12. Global Apomorphine Delivery Device Sales by Region (2025-2030) & (K Units)

Table 13. Global Apomorphine Delivery Device Sales Market Share by Region (2019-2024)

Table 14. Global Apomorphine Delivery Device Sales Market Share by Region (2025-2030)

Table 15. Global Apomorphine Delivery Device Sales by Manufacturers (2019-2024) & (K Units)

Table 16. Global Apomorphine Delivery Device Sales Share by Manufacturers (2019-2024)

Table 17. Global Apomorphine Delivery Device Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Apomorphine Delivery Device Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Apomorphine Delivery Device, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Apomorphine Delivery Device Price by Manufacturers 2019-2024 (US$/Unit)

Table 21. Global Apomorphine Delivery Device Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Apomorphine Delivery Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Apomorphine Delivery Device as of 2023)

Table 23. Global Key Manufacturers of Apomorphine Delivery Device, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Apomorphine Delivery Device, Product Offered and Application

Table 25. Global Key Manufacturers of Apomorphine Delivery Device, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Apomorphine Delivery Device Sales by Type (2019-2024) & (K Units)

Table 28. Global Apomorphine Delivery Device Sales by Type (2025-2030) & (K Units)

Table 29. Global Apomorphine Delivery Device Sales Share by Type (2019-2024)

Table 30. Global Apomorphine Delivery Device Sales Share by Type (2025-2030)

Table 31. Global Apomorphine Delivery Device Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Apomorphine Delivery Device Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Apomorphine Delivery Device Revenue Share by Type (2019-2024)

Table 34. Global Apomorphine Delivery Device Revenue Share by Type (2025-2030)

Table 35. Apomorphine Delivery Device Price by Type (2019-2024) & (US$/Unit)

Table 36. Global Apomorphine Delivery Device Price Forecast by Type (2025-2030) & (US$/Unit)

Table 37. Global Apomorphine Delivery Device Sales by Application (2019-2024) & (K Units)

Table 38. Global Apomorphine Delivery Device Sales by Application (2025-2030) & (K Units)

Table 39. Global Apomorphine Delivery Device Sales Share by Application (2019-2024)

Table 40. Global Apomorphine Delivery Device Sales Share by Application (2025-2030)

Table 41. Global Apomorphine Delivery Device Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Apomorphine Delivery Device Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Apomorphine Delivery Device Revenue Share by Application (2019-2024)

Table 44. Global Apomorphine Delivery Device Revenue Share by Application (2025-2030)

Table 45. Apomorphine Delivery Device Price by Application (2019-2024) & (US$/Unit)

Table 46. Global Apomorphine Delivery Device Price Forecast by Application (2025-2030) & (US$/Unit)

Table 47. US & Canada Apomorphine Delivery Device Sales by Type (2019-2024) & (K Units)

Table 48. US & Canada Apomorphine Delivery Device Sales by Type (2025-2030) & (K Units)

Table 49. US & Canada Apomorphine Delivery Device Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Apomorphine Delivery Device Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Apomorphine Delivery Device Sales by Application (2019-2024) & (K Units)

Table 52. US & Canada Apomorphine Delivery Device Sales by Application (2025-2030) & (K Units)

Table 53. US & Canada Apomorphine Delivery Device Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Apomorphine Delivery Device Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Apomorphine Delivery Device Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Apomorphine Delivery Device Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Apomorphine Delivery Device Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Apomorphine Delivery Device Sales by Country (2019-2024) & (K Units)

Table 59. US & Canada Apomorphine Delivery Device Sales by Country (2025-2030) & (K Units)

Table 60. Europe Apomorphine Delivery Device Sales by Type (2019-2024) & (K Units)

Table 61. Europe Apomorphine Delivery Device Sales by Type (2025-2030) & (K Units)

Table 62. Europe Apomorphine Delivery Device Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Apomorphine Delivery Device Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Apomorphine Delivery Device Sales by Application (2019-2024) & (K Units)

Table 65. Europe Apomorphine Delivery Device Sales by Application (2025-2030) & (K Units)

Table 66. Europe Apomorphine Delivery Device Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Apomorphine Delivery Device Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Apomorphine Delivery Device Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Apomorphine Delivery Device Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Apomorphine Delivery Device Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Apomorphine Delivery Device Sales by Country (2019-2024) & (K Units)

Table 72. Europe Apomorphine Delivery Device Sales by Country (2025-2030) & (K Units)

Table 73. China Apomorphine Delivery Device Sales by Type (2019-2024) & (K Units)

Table 74. China Apomorphine Delivery Device Sales by Type (2025-2030) & (K Units)

Table 75. China Apomorphine Delivery Device Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Apomorphine Delivery Device Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Apomorphine Delivery Device Sales by Application (2019-2024) & (K Units)

Table 78. China Apomorphine Delivery Device Sales by Application (2025-2030) & (K Units)

Table 79. China Apomorphine Delivery Device Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Apomorphine Delivery Device Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Apomorphine Delivery Device Sales by Type (2019-2024) & (K Units)

Table 82. Asia Apomorphine Delivery Device Sales by Type (2025-2030) & (K Units)

Table 83. Asia Apomorphine Delivery Device Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Apomorphine Delivery Device Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Apomorphine Delivery Device Sales by Application (2019-2024) & (K Units)

Table 86. Asia Apomorphine Delivery Device Sales by Application (2025-2030) & (K Units)

Table 87. Asia Apomorphine Delivery Device Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Apomorphine Delivery Device Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Apomorphine Delivery Device Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Apomorphine Delivery Device Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Apomorphine Delivery Device Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Apomorphine Delivery Device Sales by Region (2019-2024) & (K Units)

Table 93. Asia Apomorphine Delivery Device Sales by Region (2025-2030) & (K Units)

Table 94. Middle East, Africa and Latin America Apomorphine Delivery Device Sales by Type (2019-2024) & (K Units)

Table 95. Middle East, Africa and Latin America Apomorphine Delivery Device Sales by Type (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Apomorphine Delivery Device Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Apomorphine Delivery Device Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Apomorphine Delivery Device Sales by Application (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Apomorphine Delivery Device Sales by Application (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Apomorphine Delivery Device Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Apomorphine Delivery Device Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Apomorphine Delivery Device Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Apomorphine Delivery Device Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Apomorphine Delivery Device Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Apomorphine Delivery Device Sales by Country (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Apomorphine Delivery Device Sales by Country (2025-2030) & (K Units)

Table 107. Supernus Pharmaceuticals Company Information

Table 108. Supernus Pharmaceuticals Description and Major Businesses

Table 109. Supernus Pharmaceuticals Apomorphine Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Supernus Pharmaceuticals Apomorphine Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Supernus Pharmaceuticals Recent Developments

Table 112. Britannia Pharmaceuticals STADA Company Information

Table 113. Britannia Pharmaceuticals STADA Description and Major Businesses

Table 114. Britannia Pharmaceuticals STADA Apomorphine Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Britannia Pharmaceuticals STADA Apomorphine Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Britannia Pharmaceuticals STADA Recent Developments

Table 117. Ever Pharma Company Information

Table 118. Ever Pharma Description and Major Businesses

Table 119. Ever Pharma Apomorphine Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Ever Pharma Apomorphine Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Ever Pharma Recent Developments

Table 122. Evolan Pharma AB (PharmSwed) Company Information

Table 123. Evolan Pharma AB (PharmSwed) Description and Major Businesses

Table 124. Evolan Pharma AB (PharmSwed) Apomorphine Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Evolan Pharma AB (PharmSwed) Apomorphine Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Evolan Pharma AB (PharmSwed) Recent Developments

Table 127. Key Raw Materials Lists

Table 128. Raw Materials Key Suppliers Lists

Table 129. Apomorphine Delivery Device Distributors List

Table 130. Apomorphine Delivery Device Customers List

Table 131. Apomorphine Delivery Device Market Trends

Table 132. Apomorphine Delivery Device Market Drivers

Table 133. Apomorphine Delivery Device Market Challenges

Table 134. Apomorphine Delivery Device Market Restraints

Table 135. Research Programs/Design for This Report

Table 136. Key Data Information from Secondary Sources

Table 137. Key Data Information from Primary Sources

List of Figures

Figure 1. Apomorphine Delivery Device Product Picture

Figure 2. Global Apomorphine Delivery Device Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Apomorphine Delivery Device Market Share by Type in 2023 & 2030

Figure 4. Pen Injectors Product Picture

Figure 5. Infusion Pumps Product Picture

Figure 6. Global Apomorphine Delivery Device Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Apomorphine Delivery Device Market Share by Application in 2023 & 2030

Figure 8. Parkinson Disease

Figure 9. Erectile Dysfunction

Figure 10. Apomorphine Delivery Device Report Years Considered

Figure 11. Global Apomorphine Delivery Device Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Apomorphine Delivery Device Revenue 2019-2030 (US$ Million)

Figure 13. Global Apomorphine Delivery Device Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 14. Global Apomorphine Delivery Device Revenue Market Share by Region (2019-2030)

Figure 15. Global Apomorphine Delivery Device Sales 2019-2030 ((K Units)

Figure 16. Global Apomorphine Delivery Device Sales Market Share by Region (2019-2030)

Figure 17. US & Canada Apomorphine Delivery Device Sales YoY (2019-2030) & (K Units)

Figure 18. US & Canada Apomorphine Delivery Device Revenue YoY (2019-2030) & (US$ Million)

Figure 19. Europe Apomorphine Delivery Device Sales YoY (2019-2030) & (K Units)

Figure 20. Europe Apomorphine Delivery Device Revenue YoY (2019-2030) & (US$ Million)

Figure 21. China Apomorphine Delivery Device Sales YoY (2019-2030) & (K Units)

Figure 22. China Apomorphine Delivery Device Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Asia (excluding China) Apomorphine Delivery Device Sales YoY (2019-2030) & (K Units)

Figure 24. Asia (excluding China) Apomorphine Delivery Device Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Middle East, Africa and Latin America Apomorphine Delivery Device Sales YoY (2019-2030) & (K Units)

Figure 26. Middle East, Africa and Latin America Apomorphine Delivery Device Revenue YoY (2019-2030) & (US$ Million)

Figure 27. The Apomorphine Delivery Device Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 28. The Top 5 and 10 Largest Manufacturers of Apomorphine Delivery Device in the World: Market Share by Apomorphine Delivery Device Revenue in 2023

Figure 29. Global Apomorphine Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 30. Global Apomorphine Delivery Device Sales Market Share by Type (2019-2030)

Figure 31. Global Apomorphine Delivery Device Revenue Market Share by Type (2019-2030)

Figure 32. Global Apomorphine Delivery Device Sales Market Share by Application (2019-2030)

Figure 33. Global Apomorphine Delivery Device Revenue Market Share by Application (2019-2030)

Figure 34. US & Canada Apomorphine Delivery Device Sales Market Share by Type (2019-2030)

Figure 35. US & Canada Apomorphine Delivery Device Revenue Market Share by Type (2019-2030)

Figure 36. US & Canada Apomorphine Delivery Device Sales Market Share by Application (2019-2030)

Figure 37. US & Canada Apomorphine Delivery Device Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Apomorphine Delivery Device Revenue Share by Country (2019-2030)

Figure 39. US & Canada Apomorphine Delivery Device Sales Share by Country (2019-2030)

Figure 40. U.S. Apomorphine Delivery Device Revenue (2019-2030) & (US$ Million)

Figure 41. Canada Apomorphine Delivery Device Revenue (2019-2030) & (US$ Million)

Figure 42. Europe Apomorphine Delivery Device Sales Market Share by Type (2019-2030)

Figure 43. Europe Apomorphine Delivery Device Revenue Market Share by Type (2019-2030)

Figure 44. Europe Apomorphine Delivery Device Sales Market Share by Application (2019-2030)

Figure 45. Europe Apomorphine Delivery Device Revenue Market Share by Application (2019-2030)

Figure 46. Europe Apomorphine Delivery Device Revenue Share by Country (2019-2030)

Figure 47. Europe Apomorphine Delivery Device Sales Share by Country (2019-2030)

Figure 48. Germany Apomorphine Delivery Device Revenue (2019-2030) & (US$ Million)

Figure 49. France Apomorphine Delivery Device Revenue (2019-2030) & (US$ Million)

Figure 50. U.K. Apomorphine Delivery Device Revenue (2019-2030) & (US$ Million)

Figure 51. Italy Apomorphine Delivery Device Revenue (2019-2030) & (US$ Million)

Figure 52. Russia Apomorphine Delivery Device Revenue (2019-2030) & (US$ Million)

Figure 53. China Apomorphine Delivery Device Sales Market Share by Type (2019-2030)

Figure 54. China Apomorphine Delivery Device Revenue Market Share by Type (2019-2030)

Figure 55. China Apomorphine Delivery Device Sales Market Share by Application (2019-2030)

Figure 56. China Apomorphine Delivery Device Revenue Market Share by Application (2019-2030)

Figure 57. Asia Apomorphine Delivery Device Sales Market Share by Type (2019-2030)

Figure 58. Asia Apomorphine Delivery Device Revenue Market Share by Type (2019-2030)

Figure 59. Asia Apomorphine Delivery Device Sales Market Share by Application (2019-2030)

Figure 60. Asia Apomorphine Delivery Device Revenue Market Share by Application (2019-2030)

Figure 61. Asia Apomorphine Delivery Device Revenue Share by Region (2019-2030)

Figure 62. Asia Apomorphine Delivery Device Sales Share by Region (2019-2030)

Figure 63. Japan Apomorphine Delivery Device Revenue (2019-2030) & (US$ Million)

Figure 64. South Korea Apomorphine Delivery Device Revenue (2019-2030) & (US$ Million)

Figure 65. China Taiwan Apomorphine Delivery Device Revenue (2019-2030) & (US$ Million)

Figure 66. Southeast Asia Apomorphine Delivery Device Revenue (2019-2030) & (US$ Million)

Figure 67. India Apomorphine Delivery Device Revenue (2019-2030) & (US$ Million)

Figure 68. Middle East, Africa and Latin America Apomorphine Delivery Device Sales Market Share by Type (2019-2030)

Figure 69. Middle East, Africa and Latin America Apomorphine Delivery Device Revenue Market Share by Type (2019-2030)

Figure 70. Middle East, Africa and Latin America Apomorphine Delivery Device Sales Market Share by Application (2019-2030)

Figure 71. Middle East, Africa and Latin America Apomorphine Delivery Device Revenue Market Share by Application (2019-2030)

Figure 72. Middle East, Africa and Latin America Apomorphine Delivery Device Revenue Share by Country (2019-2030)

Figure 73. Middle East, Africa and Latin America Apomorphine Delivery Device Sales Share by Country (2019-2030)

Figure 74. Brazil Apomorphine Delivery Device Revenue (2019-2030) & (US$ Million)

Figure 75. Mexico Apomorphine Delivery Device Revenue (2019-2030) & (US$ Million)

Figure 76. Turkey Apomorphine Delivery Device Revenue (2019-2030) & (US$ Million)

Figure 77. Israel Apomorphine Delivery Device Revenue (2019-2030) & (US$ Million)

Figure 78. GCC Countries Apomorphine Delivery Device Revenue (2019-2030) & (US$ Million)

Figure 79. Apomorphine Delivery Device Value Chain

Figure 80. Apomorphine Delivery Device Production Process

Figure 81. Channels of Distribution

Figure 82. Distributors Profiles

Figure 83. Bottom-up and Top-down Approaches for This Report

Figure 84. Data Triangulation

Figure 85. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Apomorphine Hydrochloride Injection Market Insights Forecast to 2030

Opioid Receptor Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dopamine Agonists Market Research Report 2024

Global Dopamine Receptor Agonists Market Research Report 2025

Global Dopamine Receptor Agonists For PD Market Research Report 2025

Opioids Agonist Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tiapride Market Insights Forecast to 2030

Hydromorphone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Opioid Use Disorder Market Insights Forecast to 2030

Global Agomelatine Market Research Report 2024

Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Synthetic Opioids Market Research Report 2024

Pain Management Product Market

Global Tapentadol Market Research Report 2024

Global Portable Apomorphine Delivery Device Market Research Report 2025

Global Tapentadol Tablets Market Research Report 2024

Global Dopamine Impurity Market Research Report 2025

Dicyclomine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Levodopa Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions